Alzheimer Disease

In this video, Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C provide the take-home messages from their session “Agitation in Alzheimer’s Dementia: Progress for an Age-Old Problem” at our...

In a long-term follow-up study, Samar R. El Khoudary, PhD, MPH, BPharm, FAHA, and colleagues investigated how the quantity and quality of cardiovascular fat in women with Alzheimer disease measured during...

In a small clinical trial, researchers found that patients taking suvorexant, an FDA-approved treatment for insomnia, had reduced levels of amyloid beta (amyloid-β) and tau phosphorylation proteins, which...

In this podcast, Sri Banerjee, MD, PhD, MPH, MAS, discusses the impact of diabetes on Alzheimer disease-related dementia mortality among Black Americans, including the burden and pathophysiology of...

In this video, Madhav Thambisetty, MD, discusses a new treatment for patients with Alzheimer disease, lecanemab, recently approved by the FDA, including the presumed mechanism of action, benefits, risks,...

In this video, Gautam Dantas, PhD, discusses how the results of his study showed that altered gut bacteria may be an indicator of the earliest stages of Alzheimer disease.

In this interview, Emile d’Angremont, MSc, discusses the results of a recent study examining the use of cholinesterase inhibitors for the management of psychotic symptoms among patients with...

In this video, Gillian T. Coughlan, MS, PhD discusses her team's study results, which found that female sex, early-age menopause, and hormone therapy use beginning more than 5 years after menopause were...

In this podcast episode, Lisa Jones, interviews Amylee Amos, PhD, RDN, IFMCP, about the key arguments and controversies surrounding specific diets in relation to Alzheimer disease prevention and management,...

In this video, Paul Schulz, MD, discusses the next steps for research on the relationship between infection and Alzheimer disease. This is part three in a three-part series.